Browne L Daniel

Average Profitability
60.04%
Insider Buys Quantity
1
Insider Buys Sum
$100,019.40
Insider Sells Quantity
16
Insider Sells Sum
$5.25M

Insider Activity of Browne L Daniel

The largest purchase of all time was on 2014-11-28 and amounted to 6000 shares of Revance Therapeutics, Inc. for $100,019.

The largest sale of all time was on 2018-03-07 and amounted to 54566 shares of Revance Therapeutics, Inc. for $1.72M.

Biography of Browne L Daniel

No biography is available at this moment.

2019-03-18SaleRevance Therapeutics, Inc.
RVNC
CEO and President
11,613
0.0271%
$15.51$180,068-12.25%
2019-02-19SaleRevance Therapeutics, Inc.
RVNC
CEO and President
5,446
0.0131%
$17.68$96,285-20.23%
2018-03-16SaleRevance Therapeutics, Inc.
RVNC
CEO and President
10,904
0.0307%
$31.43$342,695-16.37%
2018-03-15SaleRevance Therapeutics, Inc.
RVNC
CEO and President
2,000
0.0058%
$32.80$65,600-18.01%
2018-03-07SaleRevance Therapeutics, Inc.
RVNC
CEO and President
54,566
0.1517%
$31.43$1.72M-16.06%
2017-11-22SaleRevance Therapeutics, Inc.
RVNC
CEO and President
7,600
0.023%
$24.94$189,570+12.67%
2017-10-18SaleRevance Therapeutics, Inc.
RVNC
CEO and President
7,662
0.0243%
$26.16$200,405+12.36%
2017-09-20SaleRevance Therapeutics, Inc.
RVNC
CEO and President
7,600
0.0246%
$23.58$179,185+21.68%
2017-08-23SaleRevance Therapeutics, Inc.
RVNC
CEO and President
22,800
0.076%
$22.76$519,031+30.04%
2017-05-24SaleRevance Therapeutics, Inc.
RVNC
CEO and President
19,713
0.066%
$20.35$401,091+35.17%
2017-05-22SaleRevance Therapeutics, Inc.
RVNC
CEO and President
12,287
0.041%
$20.20$248,159+34.28%
2017-02-22SaleRevance Therapeutics, Inc.
RVNC
CEO and President
11,037
0.0386%
$20.57$227,050+20.96%
2017-01-25SaleRevance Therapeutics, Inc.
RVNC
CEO and President
12,000
0.0414%
$19.78$237,398+20.1%
2016-12-28SaleRevance Therapeutics, Inc.
RVNC
CEO and President
12,000
0.0428%
$20.94$251,250+11.72%
2016-11-25SaleRevance Therapeutics, Inc.
RVNC
CEO and President
12,000
0.0425%
$17.92$215,005+26.39%
2016-10-26SaleRevance Therapeutics, Inc.
RVNC
CEO and President
12,000
0.0428%
$14.85$178,199+45.61%
2014-11-28PurchaseRevance Therapeutics, Inc.
RVNC
CEO and President
6,000
0.0259%
$16.67$100,019+60.04%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.